High HIV-Trypanosoma cruzi coinfection levels in vulnerable populations in Buenos Aires, Argentina

A.BENCHETRIT; G. ANDREANI; M.M. AVILA; D. ROSSI; A.M. DE RISSIO; M. WEISSENBACHER ; L. MARTINEZ PERALTA ; G. DOLCINI

AIDS RESEARCH AND HUMAN RETROVIRUSES

MARY ANN LIEBERT INC

Lugar: New York; Año: 2017 vol. 33 p. 330 - 331

0889-2229

The coinfection with Trypanosoma cruzi (T. cruzi) and HIV is a relevant clinical event. The goal of this study was to establish the frequency of coinfection in populations at risk for HIV-1 in Argentina. A total of 280 HIV positive serum samples from HIV seroprevalence studies in HIV at-risk groups were tested for T.cruzi infection. Of those samples, 8 were positive for T. cruzi (coinfection rate: 2.9%); 6 of them came from HIV positive injecting drug users (IDUs) (rate: 7.8%). In view of these results, all HIV infected patients in endemic countries should undergo T. cruzi diagnosis.